Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
32982 | 131 | 24.4 | 51% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
2 | 3 | INTEGRATIVE & COMPLEMENTARY MEDICINE//CHEMISTRY, MEDICINAL//ESSENTIAL OIL | 193989 |
3358 | 2 | BIBENZYL//ORCHIDACEAE//DIHYDROPHENANTHRENE | 1701 |
32982 | 1 | IGURATIMOD//T 614//DIMETHYL BENZOYLPHENYL UREA BPU | 131 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IGURATIMOD | authKW | 3045785 | 11% | 93% | 14 |
2 | T 614 | authKW | 2581984 | 9% | 92% | 12 |
3 | DIMETHYL BENZOYLPHENYL UREA BPU | authKW | 699288 | 2% | 100% | 3 |
4 | 3 FORMYLAMINO 7 METHYLSULFONYLAMINO 6 PHENOXY 4H 1 BENZOPYRAN 4 ONET 614 | authKW | 466192 | 2% | 100% | 2 |
5 | 1 SUBSTITUTED 1 3 DICYCLOHEXYLUREA ANALOGS | authKW | 233096 | 1% | 100% | 1 |
6 | 2 4 3 HYDROXYPROPYL 1 PIPERAZINYL ETHYL 1 4 CHLOROBENZOYL 5 METHOXY 2 METHYL 3 INDOLYLACETATE | authKW | 233096 | 1% | 100% | 1 |
7 | 3 3 DISUBSTITUTED 1 ACYL 1 PHENYL UREAS | authKW | 233096 | 1% | 100% | 1 |
8 | 3 FORMYLAMINO 7 METHYLSULFONYLAMINO 6 PHENOXY 4H 1 BENZOPYRAN 4 ONE EFFECT ON ARACHIDONIC ACID CASCADES MECHA | authKW | 233096 | 1% | 100% | 1 |
9 | 3 FORMYLAMINO 7 METHYLSULFONYLAMINO 6 PHENOXY 4H 1 BENZOPYRAN 4 ONE PHARMACOLOGY | authKW | 233096 | 1% | 100% | 1 |
10 | ACCELERATED TITRATION INTRODUCTION | authKW | 233096 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1509 | 62% | 0% | 81 |
2 | Chemistry, Medicinal | 611 | 21% | 0% | 27 |
3 | Rheumatology | 216 | 8% | 0% | 10 |
4 | Chemistry, Multidisciplinary | 80 | 18% | 0% | 24 |
5 | Immunology | 31 | 9% | 0% | 12 |
6 | Medical Laboratory Technology | 8 | 2% | 0% | 2 |
7 | Oncology | 7 | 6% | 0% | 8 |
8 | Medicine, Research & Experimental | 3 | 3% | 0% | 4 |
9 | Chemistry, Organic | 3 | 4% | 0% | 5 |
10 | Biochemical Research Methods | 2 | 2% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IST FARM TOSSICOL | 233096 | 1% | 100% | 1 |
2 | PHARMACEUT S FUKUSHIMA KU | 233096 | 1% | 100% | 1 |
3 | HANNO CHEM | 116547 | 1% | 50% | 1 |
4 | IST FARMACOL TOSSICOL | 82871 | 3% | 9% | 4 |
5 | RHEUMATOLRENJI HOSP | 77697 | 1% | 33% | 1 |
6 | ORTHOPAED SURG RHEUMATOL | 67668 | 2% | 10% | 3 |
7 | SHANGHAI RHEUMATOL | 67668 | 2% | 10% | 3 |
8 | CHEM THER EUT | 66595 | 2% | 14% | 2 |
9 | DIPARTIMENTO CHIM FARM TOSSICOL | 58272 | 1% | 25% | 1 |
10 | IST ANALIT FARMACEUT | 58272 | 1% | 25% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FARMACO | 16114 | 8% | 1% | 11 |
2 | JOURNAL OF PHARMACOBIO-DYNAMICS | 7006 | 5% | 0% | 7 |
3 | FOLIA PHARMACOLOGICA JAPONICA | 5297 | 4% | 0% | 5 |
4 | MODERN RHEUMATOLOGY | 4539 | 4% | 0% | 5 |
5 | FARMACO-EDIZIONE SCIENTIFICA | 2525 | 2% | 0% | 3 |
6 | YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 1606 | 5% | 0% | 6 |
7 | CHEMICAL & PHARMACEUTICAL BULLETIN | 1345 | 8% | 0% | 10 |
8 | JOURNAL OF IMMUNOPHARMACOLOGY | 1152 | 1% | 0% | 1 |
9 | INTERNATIONAL JOURNAL OF IMMUNOTHERAPY | 493 | 1% | 0% | 1 |
10 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 441 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OKAMURA, K , YONEMOTO, Y , OKURA, C , KOBAYASHI, T , TAKAGISHI, K , (2015) EFFICACY OF THE CLINICAL USE OF IGURATIMOD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS.MODERN RHEUMATOLOGY. VOL. 25. ISSUE 2. P. 235 -240 | 19 | 86% | 6 |
2 | MUCKE, HAM , (2012) IGURATIMOD: A NEW DISEASE-MODIFYING ANTIRHEUMATIC DRUG.DRUGS OF TODAY. VOL. 48. ISSUE 9. P. 577 -586 | 17 | 94% | 10 |
3 | OKAMURA, K , YONEMOTO, Y , SUTO, T , OKURA, C , TAKAGISHI, K , (2015) EFFICACY AT 52 WEEKS OF DAILY CLINICAL USE OF IGURATIMOD IN PATIENTS WITH RHEUMATOID ARTHRITIS.MODERN RHEUMATOLOGY. VOL. 25. ISSUE 4. P. 534 -539 | 17 | 59% | 3 |
4 | LU, LJ , BAO, CD , DAI, M , TENG, JL , FAN, W , DU, F , YANG, NP , ZHAO, YH , CHEN, ZW , XU, JH , ET AL (2009) MULTICENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS WITH T-614 COMPARED WITH METHOTREXATE.ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH. VOL. 61. ISSUE 7. P. 979 -987 | 13 | 59% | 18 |
5 | TANAKA, K , YAMAGUCHI, T , HARA, M , (2015) IGURATIMOD FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN JAPAN.EXPERT REVIEW OF CLINICAL IMMUNOLOGY. VOL. 11. ISSUE 5. P. 565 -573 | 13 | 45% | 1 |
6 | RUDEK, MA , ZHAO, M , HE, P , ZABELINA, Y , JIN, R , MESSERSMITH, WA , WOLFF, AC , BAKER, SD , (2005) VALIDATION AND IMPLEMENTATION OF A LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY ASSAY TO QUANTITATE DIMETHYL BENZOYLPHENYLUREA (BPU) AND ITS FIVE METABOLITES IN HUMAN PLASMA AND URINE FOR CLINICAL PHARMACOLOGY STUDIES.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 828. ISSUE 1-2. P. 41-54 | 7 | 88% | 1 |
7 | MESSERSMITH, WA , RUDEK, MA , BAKER, SD , ZHAO, M , COLLINS, C , COLEVAS, AD , DONEHOWER, RC , CARDUCCI, MA , WOLFF, AC , (2007) PHASE I STUDY OF CONTINUOUS WEEKLY DOSING OF DIMETHYLAMINO BENZOYLPHENYLUREA (BPU) IN PATIENTS WITH SOLID TUMOURS.EUROPEAN JOURNAL OF CANCER. VOL. 43. ISSUE 1. P. 78-86 | 9 | 50% | 3 |
8 | ANCHOORI, RK , KORTENHORST, MSQ , HIDALGO, M , SARKAR, T , HALLUR, G , BAI, RL , VAN DIEST, PJ , HAMEL, E , KHAN, SR , (2008) NOVEL MICROTUBULE-INTERACTING PHENOXY PYRIDINE AND PHENYL SULFANYL PYRIDINE ANALOGUES FOR CANCER THERAPY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 51. ISSUE 19. P. 5953 -5957 | 5 | 83% | 15 |
9 | LI, JT , MAO, HJ , LIANG, Y , LU, YR , CHEN, S , YANG, NP , SHI, GX , (2013) EFFICACY AND SAFETY OF IGURATIMOD FOR THE TREATMENT OF RHEUMATOID ARTHRITIS.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - | 6 | 60% | 5 |
10 | ZHOU, T , DING, L , LI, XM , ZHANG, F , ZHANG, Q , GONG, B , GUO, XF , (2008) DETERMINATION OF IGURATIMOD IN RAT PLASMA BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY: METHOD AND APPLICATION.BIOMEDICAL CHROMATOGRAPHY. VOL. 22. ISSUE 3. P. 260-264 | 4 | 100% | 2 |
Classes with closest relation at Level 1 |